Manual Traction and Rehabilitation After Knee Replacement Surgery
SMART-TKA
The Short-Term Impact of Manual Traction Combined With Standard Rehabilitation Protocol on Pain, Function, and Quality of Life After Total Knee Arthroplasty
1 other identifier
interventional
48
1 country
1
Brief Summary
The goal of this clinical trial is to determine whether the addition of manual traction to a standard rehabilitation protocol improves early recovery after primary total knee arthroplasty (TKA) in women aged 50-75 years with knee osteoarthritis. The main questions it aims to answer are:
- Does the addition of manual traction reduce postoperative pain during the first four weeks after TKA?
- Does manual traction improve physical function, knee range of motion, patient-reported knee function, and health-related quality of life compared with standard rehabilitation alone?
- Does manual traction reduce the need for analgesic medication during the early postoperative rehabilitation period? Researchers will compare participants receiving manual traction plus standard rehabilitation with participants receiving sham traction plus the same standard rehabilitation protocol to determine whether manual traction provides additional clinical benefits during early rehabilitation after TKA. Participants will:
- Be randomly assigned to either the manual traction group or the sham traction (control) group.
- Receive a standardized rehabilitation program for four weeks after surgery, with the intervention group receiving manual traction and the control group receiving sham traction.
- Attend supervised rehabilitation sessions five times per week throughout the four-week intervention period.
- Complete validated questionnaires assessing pain, knee function, joint awareness, and health-related quality of life at predefined assessment time points.
- Undergo standardized clinical assessments of knee range of motion and physical function before surgery, before rehabilitation, during follow-up, and one month after surgery.
- Have their analgesic medication use recorded throughout the rehabilitation period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 16, 2026
CompletedStudy Start
First participant enrolled
July 22, 2026
CompletedFirst Posted
Study publicly available on registry
July 23, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 22, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 12, 2026
July 23, 2026
July 1, 2026
3 months
July 16, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Intensity Measured by the Numeric Pain Rating Scale (NPRS)
Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS), an 11-point scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores indicate worse pain.
Baseline (preoperative) and weekly during the first four postoperative weeks (5 assessments).
Secondary Outcomes (8)
Physical Function Measured by the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS-JR)
Pre-treatment and at the fourth postoperative week.
Knee range of motion
Baseline (preoperative), pre-treatment, and at the fourth postoperative week.
Timed Up and Go Test (TUG)
At the fourth postoperative week.
Joint Perception Measured by the Forgotten Joint Score-12 (FJS-12)
At 4 weeks after surgery.
Health-Related Quality of Life Measured by the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)
Before surgery (baseline) and at 4 weeks after surgery.
- +3 more secondary outcomes
Study Arms (2)
Traction Group (TG)
EXPERIMENTALParticipants assigned to this arm will receive manual tibiofemoral traction combined with a standardized rehabilitation program following total knee arthroplasty. Manual traction will be applied by a licensed physiotherapist using the Kaltenborn mobilization technique for three weeks, with progressive traction grades and force adjusted according to the study protocol and patient tolerance. The standardized rehabilitation program will include supervised therapeutic exercises targeting pain reduction, improvement of knee range of motion, muscle strength, functional mobility, gait, and overall postoperative recovery.
Control Group (CG)
SHAM COMPARATORParticipants assigned to this arm will receive sham tibiofemoral traction combined with the same standardized rehabilitation program following total knee arthroplasty. Sham traction will replicate the positioning and therapist contact of the manual traction procedure without the application of therapeutic traction force, in order to maintain participant blinding. The standardized rehabilitation program will include supervised therapeutic exercises identical to those provided to the intervention group, targeting pain management, knee range of motion, muscle strength, functional mobility, gait, and postoperative recovery.
Interventions
Participants will receive manual tibiofemoral traction combined with a standardized rehabilitation program following total knee arthroplasty. During the first postoperative week, all participants will receive standard rehabilitation without traction. Manual traction will begin in the second postoperative week and will be applied by a physiotherapist using the Kaltenborn technique. The distal femur will be stabilized with a fixation belt, while a separate traction belt around the distal tibia and fibula will apply tibiofemoral traction with the knee in extension. Traction will progress over three weeks: Grade I in week 2 (10-15% body weight), Grade II in week 3 (15-20%), and Grade III in week 4 (20-25%). The traction grade and force will be adjusted according to patient tolerance and postoperative safety. Each session will include 30-60 seconds of traction followed by a 15-second rest interval, repeated for eight cycles. After each session, ROM (20 active,20 assisted) will be performed.
Participants assigned to the control group will receive sham tibiofemoral traction combined with the standardized rehabilitation program following total knee arthroplasty. Sham traction will simulate the manual traction procedure without the application of therapeutic traction force. The procedure will be performed to maintain participant blinding while providing the same rehabilitation protocol as the intervention group.
Eligibility Criteria
You may qualify if:
- Female patients aged between 50 and 75 years.
- Patients who will undergo primary total knee arthroplasty due to osteoarthritis, classified as Kellgren-Lawrence grades 3 to 4.
- Patients willing to participate in the study and able to provide informed consent.
You may not qualify if:
- Morbid obesity, defined as a body mass index (BMI) greater than 40 kg/m².
- Revision arthroplasty procedures.
- Presence of severe cardiac, vascular, renal, neurological, psychiatric, or other orthopedic conditions affecting the lower limb and limiting functional abilities.
- Active infections or contraindications to physical therapy.
- Inability to comply with the prescribed rehabilitation protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Alma Mater Europaea - Slovenialead
- University Clinical Centre of Kosovacollaborator
- Royal Medical Hospital LLC.collaborator
Study Sites (1)
University Clinical Center of Kosovo (UCCK) - Clinic of Physical Medicine and Rehabilitation
Pristina, Pristina District, 10000, Kosovo
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MIMOZE ZOGAJ, MSc
Alma Mater Europaea - Slovenia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants and outcome assessors will be blinded to treatment allocation. Participant blinding will be maintained through the use of sham traction in the control group. Due to the nature of the intervention, the treating physiotherapist cannot be blinded and will not be involved in outcome assessment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Candidate
Study Record Dates
First Submitted
July 16, 2026
First Posted
July 23, 2026
Study Start
July 22, 2026
Primary Completion (Estimated)
October 22, 2026
Study Completion (Estimated)
November 12, 2026
Last Updated
July 23, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because the study involves identifiable clinical data collected from human participants. Data will be protected to ensure participant confidentiality and privacy in accordance with ethical approval requirements and applicable data protection regulations. Only aggregated, de-identified study results will be reported in scientific publications.